Moxidectin being tested for onchocerciasis
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The...
View ArticleAvermectin family of drugs shows promise against TB
A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia...
View ArticleMoxidectin being tested for onchocerciasis
A clinical trial is being launched in three African countries of a drug that could eliminate onchocerciasis, or river blindness, one of the leading infectious causes of blindness across Africa. The...
View ArticleAvermectin family of drugs shows promise against TB
A well-established family of drugs used to treat parasitic diseases is showing surprising potential as a therapy for tuberculosis (TB), according to new research from University of British Columbia...
View ArticleUniversity of Alicante study: Antiparasitic Ivermectin six times more toxic...
Ivermectin is six times more toxic than Moxidectin for insects in charge of the recycling of organic matter. For the first time ever, there is scientific evidence based on physiological studies and...
View ArticleStudy identifies a host of agents with anti-SARS-CoV-2 potential
A team of researchers at the Genomics Research Center, Academia Sinica, in Taiwan, evaluated the efficacy of 2,855 agents against SARS-CoV-2.
View Article
